Dan Zabrowski - 12 Aug 2024 Form 4 Insider Report for ACTUATE THERAPEUTICS, INC. (ACTU)

Role
Director
Signature
/s/ Paul Lytle, Attorney-In-Fact
Issuer symbol
ACTU
Transactions as of
12 Aug 2024
Net transactions value
$0
Form type
4
Filing time
14 Aug 2024, 19:30:35 UTC
Previous filing
25 Aug 2023
Next filing
23 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ACTU Non-Qualified Stock Options Award $0 +15,000 $0.000000 15,000 12 Aug 2024 Common Stock 15,000 $8.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 15,000 stock options granted upon the effectiveness of the registration statement for the issuer's initial public offering on August 12, 2024, which vest in full on the first anniversary of the grant date.